Skip to content

LinkedIn
Facebook

HR SLO CZ BiH

Belupo EN
HR SLO CZ BiH

About us
- Core values
- Strategy
- Markets
- Management Board
  - Hrvoje Čeović, PhD
  - Tihomir Heđever
  - Nenad Pavletić
- Supervisory Board
- History
Sustainability
Products
- Over-the-counter (OTC) products
- Pain and Fever
  - Neofen
  - Lupocet
  - Knavon akut
  - Luboreta
- Heart and Blood Vessels
  - Aska pro
- Allergies
  - Belodin A
  - Belodin A derm gel
  - Rinil
- Cold, flu, cough, sore throat
  - Lupocet trio
  - Lupocet flu forte
  - Rinil
  - Hederan
  - Naxil
  - Naxil forte
  - Zynol sprej za usnu sluznicu
- Liver and digestive system
  - Silymarin
  - Lordiar
  - Portalak
- Skin, hair, nails
  - Belupo Skin Solutions
  - Alomax
  - Belodin A derm gel
  - Rojazol derm
  - Herplex
  - Amofin
  - Belodex
- Oral health
  - Belosept
  - Zynol 1,5 mg/ml sprej
  - Zynol 3 mg/ml sprej
- Fungal infections
  - Rojazol derm
  - Amofin
- See all products

Careers
- Job and career
- Education and development
- Students
News
- Media
- Social media
- Photographs, graphic and video materials
- Websites
Zdravo budi
Belupoint
Contact

LinkedIn
Facebook

Home

Contact

First and last name *

E-mail address *

Your message *

I agree/accept that Belupo d.d. collects and processes my personal data exclusively for the purpose of handling my request/inquiry, in accordance with applicable personal data protection regulations. I hereby confirm that I am familiar with the Privacy policy.

You can also contact us directly via email.

Koprivnica

belupo@belupo.hr

Ulica Danica 5, 48 000 Koprivnica

Zagreb

belupo@belupo.hr

(01) 24 81 222
(01) 24 81 213

Radnička cesta 21, 10 000 Zagreb

Reporting side effects

pharmacovigilance@belupo.hr

Media

public.relations@belupo.hr

Data protection officer

Human resources

ljudski.potencijali@belupo.hr

Share this page

Linkedin
Facebook
X
Pinterest
E-mail

© 2025. Belupo d.d. All rights reserved

Belupo d.d. is owned by Podravka d.d. (Inc.)

Sitemap
Privacy Policy
Terms of Use
Reporting side effects
Complaints

Contact
Media
Investors
Cookies

Linkedin
Facebook
Instagram